BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38608472)

  • 1. Differences in nature killer cell response and interference with mitochondrial DNA induced apoptosis in moxifloxacin environment.
    Wang M; Wu H; Jiang W; Ren Y; Yuan X; Wang Y; Zhou J; Feng W; Wang Y; Xu T; Zhang D; Fang Y; He C; Li W
    Int Immunopharmacol; 2024 May; 132():111970. PubMed ID: 38608472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.
    Reuveni D; Halperin D; Shalit I; Priel E; Fabian I
    Int J Oncol; 2010 Aug; 37(2):463-71. PubMed ID: 20596674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bidirectional effects of moxifloxacin on the pro‑inflammatory response in lipopolysaccharide‑stimulated mouse peritoneal macrophages.
    Qiu Z; Yuan H; Li N; Yang X; Hu X; Su F; Chen B
    Mol Med Rep; 2018 Dec; 18(6):5399-5408. PubMed ID: 30365072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of moxifloxacin-induced cytotoxicity on human corneal endothelial cells.
    Park JH; Kim M; Chuck RS; Park CY
    Sci Rep; 2021 Mar; 11(1):6250. PubMed ID: 33737688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells.
    Fabian I; Reuveni D; Levitov A; Halperin D; Priel E; Shalit I
    Br J Cancer; 2006 Oct; 95(8):1038-46. PubMed ID: 17047652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.
    Carson WE; Fehniger TA; Caligiuri MA
    Eur J Immunol; 1997 Feb; 27(2):354-60. PubMed ID: 9045904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
    Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
    Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory drugs Revlimid (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation.
    Zhu D; Corral LG; Fleming YW; Stein B
    Cancer Immunol Immunother; 2008 Dec; 57(12):1849-59. PubMed ID: 18392823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trophoblast cell influence on peripheral blood natural killer cell proliferation and phenotype in non-pregnant women and women in early pregnancy.
    Mikhailova VA; Kudryavtsev IV; Serebryakova MK; Milyutina YP; Demidova ES; Panina AN; Bazhenov DO; Belikova ME; Selkov SA; Sokolov DI
    Immunobiology; 2020 May; 225(3):151910. PubMed ID: 32044150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Coated Rituximab Induces Highly Cytotoxic Natural Killer Cells From Peripheral Blood Mononuclear Cells
    Niu C; Chen Y; Li M; Zhu S; Zhou L; Xu D; Li Z; Xu J; Li W; Wang Y; Cui J
    Front Immunol; 2021; 12():658562. PubMed ID: 34113342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells.
    Aktas E; Akdis M; Bilgic S; Disch R; Falk CS; Blaser K; Akdis C; Deniz G
    Clin Exp Immunol; 2005 May; 140(2):301-9. PubMed ID: 15807855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human natural killer cells by the novel innate immune modulator recombinant Eimeria antigen.
    Aylsworth CF; Aldhamen YA; Seregin SS; Godbehere S; Amalfitano A
    Hum Immunol; 2013 Aug; 74(8):916-26. PubMed ID: 23639554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines elevated in patients with HBV-related acute-on-chronic liver failure promote NK cell mediated cytotoxicity through TRAIL.
    Wan Z; Xie G; Wu Y; Liu F; Xin S; You S; Liu H; Li C; Li D
    Dig Liver Dis; 2016 May; 48(5):528-535. PubMed ID: 26860239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of Metabolic Pathways in Circulating Natural Killer Cells Isolated from Inflammatory Bowel Disease Patients.
    Zaiatz Bittencourt V; Jones F; Tosetto M; Doherty GA; Ryan EJ
    J Crohns Colitis; 2021 Aug; 15(8):1316-1325. PubMed ID: 33460436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
    Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
    Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of cell movement impairs survival of peripheral blood IL-2-stimulated natural killer cells originating from solid cancer and promotes red blood cells to induce their switch toward a regulatory phenotype.
    Hadjidj Z; Messali R; Aribi M
    Immunol Lett; 2020 May; 221():6-17. PubMed ID: 32027874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.